Abcam to Report Full Year Results on Monday, March 20, 2023

Rhea-AI Summary

Abcam plc will announce its full-year results for the year ending 31 December 2022 on 20 March 2023 at 7:00 a.m. ET. Following the results, the Company will hold a live teleconference and webcast at 8:00 a.m. ET. Investors can access the webcast through the provided link or via the Company's investor section on its website. Abcam is a global leader in life science research tools, serving around 750,000 researchers in over 130 countries. The Company aims to enhance biological understanding and disease treatment through innovative reagents and tools.

CAMBRIDGE, England and WALTHAM, Mass., March 10, 2023 /PRNewswire/ -- Abcam plc (Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, will report its results for the year ended 31 December 2022 at 7.00 a.m. ET on 20 March 2023.

Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. ET that same day (details below).

To access the webcast, please use the following link:

https://events.q4inc.com/earnings/LONABC/FY22

The press release and the live audio webcast will also be available in the investor section of Abcam's corporate website at corporate.abcam.com/investors/reports-presentations/.  An archive will be available after the call at that same address.

For further information please contact:

Abcam
Tommy Thomas, CPA, Vice President, Investor Relations	+1 617 577 4205

About Abcam plc

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays and other research tools to address important targets in critical biological pathways.

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.

Abcam's worldwide customer base of approximately 750,000 life science researchers uses Abcam's antibodies, reagents, biomarkers and assays. By actively listening to and collaborating with these researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.

Founded in 1998 and headquartered in Cambridge, UK, the Company has served customers in more than 130 countries. Abcam's American Depositary Shares (ADSs) trade on the Nasdaq Global Market (Nasdaq: ABCM).

For more information, please visit www.abcam.com or www.abcamplc.com

Logo - https://mma.prnewswire.com/media/1670705/Abcam_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/abcam-to-report-full-year-results-on-monday-march-20-2023-301768357.html

SOURCE Abcam plc

FAQ

What time will Abcam report its annual results?

Abcam will report its annual results on March 20, 2023, at 7:00 a.m. ET.

How can I access Abcam's results webcast?

You can access Abcam's results webcast on March 20, 2023, at 8:00 a.m. ET via the link provided in their announcement.

What is the ticker symbol for Abcam?

Abcam's ticker symbol is ABCM on the Nasdaq.

When does Abcam's financial year end?

Abcam's financial year ends on December 31.

How many researchers use Abcam's products?

Approximately 750,000 life science researchers utilize Abcam's tools and reagents.